Pasithea Therapeutics Corp. (KTTA )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol KTTA
- Company Pasithea Therapeutics Corp.
- Price $3.95
- Changes Percentage -16.49
- Change -0.78
- Day Low $3.95
- Day High $4.59
- Year High $17.4
- Year Low $3.61
- Market Cap $4,124,120
- Price Avg 50 EMA (D) $4.71
- Price Avg 200 EMA (D) $6.14
- Exchange NASDAQ
- Volume 96,535
- Average Volume 931,256
- Open $4.59
- Previous Close $4.73
- EPS -14.79
- PE -0.27
- Earnings Announcement 2024-11-27 12:00:00
- Shares Outstanding $1,044,081
Company brief: PASITHEA THERAPEUTICS CORP. (KTTA )
- Healthcare
- Biotechnology
- Dr. Tiago Reis Marques M.D., Ph.D.
- https://www.pasithea.com
- US
- N/A
- 09-15-2021
- US70261F2020
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.